The Alberta Vascular Risk Reduction Community Pharmacy Project: RxEACH
Condition(s):Diabetes; Chronic Kidney Disease; Established Atherosclerotic Vascular Disease; Framingham Risk Score More Than 20 PercentLast Updated:October 30, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Diabetes; Chronic Kidney Disease; Established Atherosclerotic Vascular Disease; Framingham Risk Score More Than 20 PercentLast Updated:October 30, 2017Completed
Condition(s):Heart FailureLast Updated:June 11, 2020Unknown status
Condition(s):Screening; Advanced Liver FibrosisLast Updated:January 11, 2024Recruiting
Condition(s):Advanced Lung Non-Small Cell CarcinomaLast Updated:January 23, 2024Recruiting
Condition(s):Renal DiseaseLast Updated:September 13, 2023Completed
Condition(s):Esophageal Varices; Non-alcoholic Fatty Liver; Compensated CirrhosisLast Updated:January 11, 2024Completed
Condition(s):Wounds and Injuries; Burns; Mohs Surgery; Diabetic Foot Ulcer Mixed; Venous Leg Ulcer; Non-healing Wound; Trauma Injury; Injury and Wounds; Degloving InjuriesLast Updated:March 25, 2024Not yet recruiting
Condition(s):Advanced Colorectal CancerLast Updated:July 27, 2023Not yet recruiting
Condition(s):Colorectal AdenomaLast Updated:January 14, 2013Unknown status
Condition(s):Patients With Advanced Treatment Naive LCNECLast Updated:March 2, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.